Literature DB >> 25789345

PURLs: A new adjunctive Tx option for venous stasis ulcers.

Benjamin H Crenshaw1, Kortnee Y Roberson2, James J Stevermer1.   

Abstract

Adding simvastatin to standard wound care improves ulcer healing rates and times as well as the patient's quality of life.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25789345      PMCID： PMC4370951     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  5 in total

1.  Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial.

Authors:  Odd Erik Johansen; Kåre Inge Birkeland; Anders Palmstrøm Jørgensen; Elsa Orvik; Beate Sørgård; Bjørn Rino Torjussen; Thor Ueland; Pål Aukrust; Lars Gullestad
Journal:  J Diabetes       Date:  2009-06-02       Impact factor: 4.006

2.  Simvastatin as a novel therapeutic agent for venous ulcers: a randomized, double-blind, placebo-controlled trial.

Authors:  M T P Evangelista; M F A Casintahan; L L Villafuerte
Journal:  Br J Dermatol       Date:  2014-05       Impact factor: 9.302

3.  Diagnosis and treatment of venous ulcers.

Authors:  Lauren Collins; Samina Seraj
Journal:  Am Fam Physician       Date:  2010-04-15       Impact factor: 3.292

4.  Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.

Authors:  Anna Abou-Raya; Suzan Abou-Raya; Madihah Helmii
Journal:  J Rheumatol       Date:  2008-08-15       Impact factor: 4.666

5.  Efficacy of topical atorvastatin for the treatment of pressure ulcers: a randomized clinical trial.

Authors:  Shadi Farsaei; Hossein Khalili; Effat Sadat Farboud; Iman Karimzadeh; Mohammad Taghi Beigmohammadi
Journal:  Pharmacotherapy       Date:  2013-08-12       Impact factor: 4.705
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.